Adverse events124

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 124

Type	Event	Organ system	Group	Affected	At risk	Events
other	Diarrhoea	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	20	26	66
other	Diarrhoea	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	18	30	58
other	Nausea	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	12	26	18
other	Nausea	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	11	30	13
other	Vomiting	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	5	26	5
other	Vomiting	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	9	30	12
other	Abdominal pain	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	6	26	10
other	Abdominal pain	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	6	30	10
other	Abdominal pain discomfort	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	3	26	5
other	Abdominal pain discomfort	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	3	30	3
other	Abdominal pain upper	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	4	26	5
other	Abdominal pain upper	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	2	30	2
other	Flatulence	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	3	26	3
other	Flatulence	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	3	30	3
other	Abdominal distension	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	1	26	2
other	Abdominal distension	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	1	30	1
other	Constipation	Gastrointestinal disorders	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	1	26	1
other	Constipation	Gastrointestinal disorders	Arm B: Pyronaridine-artesunate 60-day Redosing	0	30	0
other	Alanine aminotransferase increased	Investigations	Arm A: Metoprolol DDI and Pyronaridine-artesunate 90-day Redosing	13	26	17
other	Alanine aminotransferase increased	Investigations	Arm B: Pyronaridine-artesunate 60-day Redosing	16	30	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01523002/events

API reference For AI assistants

Adverse events124

Sources 3

Read this list from software.